154 related articles for article (PubMed ID: 16367746)
1. Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus.
Bedouelle H; Belkadi L; England P; Guijarro JI; Lisova O; Urvoas A; Delepierre M; Thullier P
FEBS J; 2006 Jan; 273(1):34-46. PubMed ID: 16367746
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.
Lisova O; Belkadi L; Bedouelle H
J Mol Recognit; 2014 Apr; 27(4):205-14. PubMed ID: 24591178
[TBL] [Abstract][Full Text] [Related]
3. Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus.
Lisova O; Hardy F; Petit V; Bedouelle H
J Gen Virol; 2007 Sep; 88(Pt 9):2387-2397. PubMed ID: 17698647
[TBL] [Abstract][Full Text] [Related]
4. Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein.
Huang KC; Lee MC; Wu CW; Huang KJ; Lei HY; Cheng JW
Proteins; 2008 Feb; 70(3):1116-9. PubMed ID: 18004779
[No Abstract] [Full Text] [Related]
5. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
Goncalvez AP; Purcell RH; Lai CJ
J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
[TBL] [Abstract][Full Text] [Related]
6. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
Lok SM; Kostyuchenko V; Nybakken GE; Holdaway HA; Battisti AJ; Sukupolvi-Petty S; Sedlak D; Fremont DH; Chipman PR; Roehrig JT; Diamond MS; Kuhn RJ; Rossmann MG
Nat Struct Mol Biol; 2008 Mar; 15(3):312-7. PubMed ID: 18264114
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
Hong WW; Yen YH; Wu SC
Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
[TBL] [Abstract][Full Text] [Related]
8. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
[TBL] [Abstract][Full Text] [Related]
12. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
[TBL] [Abstract][Full Text] [Related]
14. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.
Gromowski GD; Roehrig JT; Diamond MS; Lee JC; Pitcher TJ; Barrett AD
Virology; 2010 Nov; 407(2):237-46. PubMed ID: 20832836
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code.
Fellouse FA; Barthelemy PA; Kelley RF; Sidhu SS
J Mol Biol; 2006 Mar; 357(1):100-14. PubMed ID: 16413576
[TBL] [Abstract][Full Text] [Related]
16. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
[TBL] [Abstract][Full Text] [Related]
17. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.
Lin B; Parrish CR; Murray JM; Wright PJ
Virology; 1994 Aug; 202(2):885-90. PubMed ID: 7518164
[TBL] [Abstract][Full Text] [Related]
18. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
[TBL] [Abstract][Full Text] [Related]
19. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
